TN maintains a comprehensive listing of radiology and radiation oncology specialty meetings, events and educational summits

ITN’s award-winning editorial team delivers industry trends and technology information to the professionals who make purchasing decisions. ITN maintains a comprehensive listing of radiology and radiation oncology specialty meetings, events and educational summits on its website at www.itnonline.com/events. Find the dates, location and links to radiology/radiation oncology conferences and education in one location.

August 24, 2023 — Medical imaging via X-rays, CT scans, MRIs and ultrasounds provide health-care professionals with unique perspectives and a better understanding of what’s happening inside a patient’s body. Using various forms of waves, these machines can visualize many unseen ailments and diseases. 

Imaging in Copenhagen 2024

August 23, 2023 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic imaging and medical informatics solutions, announced FDA 510(k) clearance of its new 1.5 Tesla magnetic resonance imaging (MRI) system, the ECHELON Synergy.

August 23, 2023 — RefleXion Medical, a therapeutic oncology company, today announced that the first patient has completed treatment with SCINTIX biology-guided radiotherapy on the 

August 23, 2023 — iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Health Canada has issued a device license for ProFound Risk version 2.0, the latest version of iCAD's personalized 1-2 year

August 23, 2023 — With the goal of ensuring access to safe and clinically useful AI for all pediatric patients, the American College of Radiology (ACR) Pediatric Artificial Intelligence (AI) workgroup recently published a white paper to educate the radiology community about health equity issues related to pediatric AI.

August 22, 2023 — Using MRI as a screening test alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to new research from UCL, UCLH and King’s College London

August 22, 2023 — iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Health Canada has issued a device license for ProFound Risk version 2.0, the latest version of iCAD's personalized 1-2 year breast cancer risk assessment solution. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now